August 13, 2009 — Combination and sequential single-agent chemotherapy are both reasonable treatment options for patients with metastatic breast cancer but, based on the available data, the European ...
Both combination and sequential single-agent chemotherapy are reasonable options to treat metastatic breast cancer, but the choice between the two should ultimately be based on patient- and ...
Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Hematopoietic Growth Factor PIXY321 After Moderate-Dose Fluorouracil, Doxorubicin, and Cyclophosphamide in Stage II and III Breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback